Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients
Acta Dermato-Venereologica · 28.08.2024 · 104 · adv40555
DOI: 10.2340/actadv.v104.40555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, online erschienen am 28.08.2024. Verfasst von Ji Su Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul National University Hospital, Seoul, Korea; Laboratory of Cutaneous Aging and Hair Research, Clinical Research Insti…. Hauptthemen laut MEDLINE: Lung Neoplasms, Protein Kinase Inhibitors, ErbB Receptors, Drug Eruptions. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Skin toxicities caused by epidermal growth factor receptor tyrosine kinase inhibitors can affect patient quality of life and lead to treatment adjustments, including dose reduction or discontinuation. This retrospective study aimed to profile skin toxicities and their impact on treatment adjustments. A total of 288 non-small cell lung cancer patients treated with first-, second-, or third-generation epidermal growth factor receptor tyrosine kinase inhibitors were included. Skin toxicities, including papulopustular rash, xerosis, paronychia, and pruritus, were assessed based on medical records, and their severity was evaluated based on the required dermatological intervention. Papulopustular rash was the most common toxicity (74.3%), followed by pruritus (61.1%), xerosis (52.4%), and paronychia (39.6%). Papulopustular rash was more common in males and more severe in younger patients. Papulopustular rash was more prevalent in patients treated with first- and second-generation epidermal growth factor receptor tyrosine kinase inhibitors, while paronychia was notably frequent for the second-generation epidermal growth factor receptor tyrosine kinase inhibitors. Second-generation epidermal growth factor receptor tyrosine kinase inhibitors frequently caused multiple skin toxicities. Importantly, skin toxicities led to epidermal growth factor receptor tyrosine kinase inhibitor treatment adjustments in 26.7% of cases, with second-generation epidermal growth factor receptor tyrosine kinase inhibitors demonstrating higher adjustment rates. Papulopustular rash and paronychia were the main causes of treatment adjustments, with even mild paronychia being linked to treatment adjustments. Effective management of skin toxicities is essential for optimizing treatment outcomes in patients receiving epidermal growth factor receptor tyrosine kinase inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Seoul National University Hospital, Seoul, Korea; Laboratory of Cutaneous Aging and Hair Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea; Institute of H…
- Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
- Department of Dermatology, Seoul National University Hospital, Seoul, Korea; Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
Zitieren
APA
Lee, J. S., Woo, J., Kim, T. M., Kim, N., Keam, B., & Jo, S. J. (2024). Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients. Acta Dermato-Venereologica, 104, adv40555. https://doi.org/10.2340/actadv.v104.40555
Vancouver
Lee JS, Woo J, Kim TM, Kim N, Keam B, Jo SJ. Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients. Acta Dermato-Venereologica. 2024;104:adv40555. doi:10.2340/actadv.v104.40555
BibTeX
@article{Lee2024,
author = {Lee, Ji Su and Woo, Jimin and Kim, Tae Min and Kim, Namkyu and Keam, Bhumsuk and Jo, Seong Jin},
title = {Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients},
journal = {Acta Dermato-Venereologica},
year = {2024},
volume = {104},
pages = {adv40555},
doi = {10.2340/actadv.v104.40555}
}
EUVIMED